ARTICLE | Company News
Tarceva gets CHMP positive opinion
June 28, 2005 1:04 AM UTC
The EMEA's CHMP issued a positive opinion to Roche (SWX:ROCZ) for Tarceva erlotinib to treat advanced or metastatic non-small cell lung cancer (NSCLC) patients for whom chemotherapy has failed. A deci...